Analysts’ views on UnitedHealth Group
UnitedHealth Group (UNH) is one of the largest Fortune 500 companies. It’s the largest health insurer in the United States. The company operates across two divisions: UnitedHealthcare and Optum. In this part of the series, we’ll look at analysts’ recommendations for UNH stock.
As of September 24, according to a Reuters survey of 24 analysts covering UNH stock, ten analysts have recommended a “strong buy,” and 13 have recommended a “buy.” Only one analyst has recommended a “hold.” None of the analysts have rated the stock a “sell.”
According to these analysts, the consensus target price for UNH stock is $290.62. That represents a return of ~8.7% for the next 12 months based on UNH’s closing price of $267.36 on September 24.
Analysts’ average target prices for peers Aetna (AET), Cigna (CI), and Anthem (ANTM) are $203.73, $225.61, and $299.05, respectively. Those target prices imply 12-month return potentials of 0.16%, 11%, and 9.5%, respectively.